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ABSTRACT
This work describes the novel use of tolC as a
selectable/counter-selectable marker for the facile
modification of DNA in Escherichia coli. Expression
of TolC (an outer membrane protein) confers
relative resistance to toxic small molecules, while
its absence renders the cell tolerant to colicin E1.
These features, coupled with the jredgam recombi-
nation system, allow for selection of tolC insertions/
deletions anywhere on the E. coli chromosome or on
plasmid DNA. This methodology obviates the need
for minimal growth media, specialized wash proto-
cols and the lengthy incubation times required
by other published recombineering methods. As a
rigorous test of the TolC selection system, six out
of seven 23S rRNA genes were consecutively and
seamlessly removed from the E. coli chromosome
without affecting expression of neighboring genes
within the complex rrn operons. The resulting
plasmid-free strain retains one 23S rRNA gene
(rrlC) in its natural location on the chromosome
and is the first mutant of its kind. These new rRNA
mutants will be useful in the study of rRNA gene
regulation and ribosome function. Given its high
efficiency, low background and facility in rich media,
tolC selection is a broadly applicable method for the
modification of DNA by recombineering.
INTRODUCTION
The tolC gene resides in an operon at 68.5min on the
Escherichia coli chromosome and precedes three non-
essential open reading frames of unknown function (1,2).
Sequence analysis and expression proﬁling postulate tolC
to be transcribed from a tandem promoter (3). One study
reports that tolC may fall under control of the mar-sox
regulon (4), and other studies suggest the two-component
system EvgAB regulates tolC (5,6). The gene itself encodes
a 493 amino acid outer membrane protein with a signal
sequence that allows SecB-dependent translocation (7,8).
Once in the periplasm, mature TolC monomers undergo
factor-independent assembly to form trimers subsequent
to outer membrane insertion (9). Electron microscopy and
X-ray crystallography have revealed a unique structure
and topography for TolC (10) with the trimer existing
as a trans-periplasmic tunnel, 140A ˚ in length (11). Upon
interaction with various inner-membrane pumps and
translocases, TolC plays an important role in hemolysin
secretion (12,13), protein import (14,15) and antibiotic
eﬄux (10,16). In E. coli for instance, the AcrB-TolC eﬄux
system pumps a diverse set of small molecules from the
cell that include novobiocin, erythromycin and sodium
dodecyl sulfate (SDS).
In addition to its role in expelling toxic compounds
from the cell, surface-exposed loops of the TolC channel
provide for speciﬁc interactions with bacteriophage (17)
and for the import of bacteriocins such as colicin E1 (18).
Bacteriocins are bactericidal proteins that constitute part
of an antimicrobial defense system and can be found in
most bacterial genera and in the archaea as well (19). Most
bacteriocins are large proteins and, in the case of colicins,
the genes encoding these toxins reside typically on extra-
chromosomal elements (20). Group A colicins demon-
strate diverse mechanisms of action and have a narrow
killing spectrum. They bind to the E. coli vitamin B
receptor BtuB and are dependent upon the Tol proteins
for transport (15,21). Colicin E1 (522 amino acids in
length) requires TolC exclusively for access to the cyto-
plasmic membrane where it forms voltage-gated ion
channels to disrupt the bilayer and kill the cell (22).
The ﬁrst tol mutants demonstrated a colicin tolerant
phenotype (18). Such mutants lost their sensitivity to
particular colicins but fully maintained the ability to
adsorb toxin on the cell surface through BtuB. Mutations
at the tolC locus diﬀer from those at other tol loci, in that
they make the cell tolerant only to colicin E1, while such
mutants respond with full sensitivity to other group A
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basis for testing tolC’s utility as a selectable/counter-
selectable marker in genome engineering studies.
Recent years have witnessed remarkable advances in the
application of new tools for the in vivo manipulation of
DNA (24–28). Perhaps the most eﬃcient of these tools is
the bacteriophage l-Red recombinase (29). This system
has been used to ‘recombineer’ genomic and extra chro-
mosomal DNA in E. coli through simple introduction
of double- or single-stranded DNA substrates into the
bacterial cell (30). The eﬃciency of the system is enhanced
greatly by the incorporation of selectable genetic markers
to assist in the identiﬁcation of desired recombinants
and a number of methods exist for constructing point
mutations, deletions and in-frame fusions (31–36). Recent
work has demonstrated continued improvements to these
approaches such as the use of galK and thyA. These genes
encode single open reading frames each able to function
as both a selectable and counter-selectable marker (37,38),
but some practical limitations remain. Current protocols
for these markers involve extensive washing of cells and
the use of specialized media during selection. In addition,
the requirement of minimal media for cell growth often
results in a delay of 2–3 days before new mutant colonies
can be chosen for further manipulation.
The following report describes the novel use of tolC as
a selectable/counter-selectable marker for recombination-
mediated genetic engineering in E. coli. This new system
maintains the ﬂexibility and eﬃciency of the latest
recombineering approaches while eliminating the need
for specialized media and extended incubation times.
To demonstrate the utility of the tolC single-gene marker
system, deletions, point mutations and gene fusions were
made to a variety of coding regions on the E. coli chromo-
some and on plasmid DNA. In addition, six of the seven
23S rRNA genes were seamlessly deleted from the E. coli
genome using one universal recombination cassette. The
resulting strain (containing a single functioning 23S rRNA
gene) shows no polar eﬀects on rRNA transcription and
serves as a new tool for the study of rRNA gene regulation
and ribosome function.
MATERIALS AND METHODS
Bacterial strains
Escherichia coli DY329 (W3110 DlacU169, nadA::Tn10,
gal490, l cI857 [cro-bio]) was a generous gift of Don
Court (28) and used with permission under US Public
Health Service License Number L-159-2006/0. It contains
a defective l prophage expressing the gam, bet and
exo recombination functions from the cI857 regulated pL
promoter. All bacterial strains constructed during this
work are derivatives of RS205 (a nad
+ derivative of strain
DY329) that was engineered according to the methods
outlined in (39). A list of all bacterial strains can be found
in Supplementary Data, Table S1.
Media and reagents
Bacterial strains were propagated on Luria Bertani broth
and agar (Difco, BD Biosciences Franklin Lakes, NJ)
according to (40). Agar plates for SDS (Fluka,
Switzerland) selection were prepared according to
standard procedures with an optimal concentration of
0.01% (w/v). Colicin E1 (SigmaAldrich St Louis, MO)
selection was performed in 0.1ml broth at a ﬁnal concen-
tration of 2 units/ml (see subsequently). DNA oligonucleo-
tides were purchased from Integrated DNA Technologies
(Coralville, IA) and a list describing their attributes can be
found in Supplementary Data, Table S2. Linear dsDNA
substrates were prepared using the GC-Rich PCR system
(Roche Applied Science Indianapolis, IA) and puriﬁed
following electrophoresis according to standard methods
(41) using the WizardSV-Gel Clean-Up system (Promega
Madison, WI). All PCR screening was performed with
JumpStart REDTaq Ready Mix (SigmaAldrich) on
puriﬁed, single bacterial colonies. Antibiotics and other
bulk chemicals were purchased from SigmaAldrich.
Linear DNA substrate design,redgam induction
and selection of recombinants
The tolC gene was removed from its location at 68.5min
on the E. coli chromosome by linear DNA transformation
of redgam-induced cells with a 70-base single-stranded
oligonucleotide (Rx-P15) of the following sequence:
50-TTTCAGCGACGTTTGACTGCCGTTTGAGCAGT
C-ATATGACGACGACGGGGCTTCGGCCCCGTCT
GAACGT-30 (Figure 1A). Colicin E1 selection was
performed (see subsequently) and transformants were
screened by PCR for the presence of a 310 base-pair (bp)
product using Primers Rx-P19 (50-GTTTCTCGTGCAAT
AATTTCTACATC-30) and Rx-P20 (50-CGTATGGAT
TTTGTCCGTTTCA-30). A tolC
  phenotype was con-
ﬁrmed by patching single colonies on 0.01% SDS agar
and by cross streak against colicin E1 [plate receptor
test- (23)].
A cassette containing the tolC gene (and upstream
promoter sequence) was ampliﬁed by PCR from strain
RS205 gDNA to serve directly as a linear DNA substrate.
Primer design adhered to the following general
scheme: 50-N50-TTGAGGCACATTAACGCCCTAT-30
and 50-N50-CCCCGTCGTCGTCATCAG-30, where ‘N’
represents nucleotides comprising the homology arms
necessary for recombination. These tails share sequence
identity with the regions of DNA ﬂanking a target gene
(Figure 1B). A 1.62kb PCR product is generated using
such primers and allows tolC expression when integrated
into the chromosome (or plasmid DNA) via the 50-bp
long tails. For experiments where the tolC ORF is used for
exchange with a target open reading frame (i.e. no pro-
moter), the following primer pair is used: 50-N50-ATG
AAGAAATTGCTCCCCATTCT-30 and 50-N50-TCAGT
TACGGAAAGGGTTATGACC-30. SDS
R transformants
are then screened for proper positioning of tolC using
PCR with primers speciﬁc for regions ﬂanking the target
gene. Appropriate chromosomal rearrangements are con-
ﬁrmed by DNA sequencing. Removal of the tolC cassette
followed the general strategy outlined in the previous
paragraph.
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and counter-selectable marker
RS205 and other derivatives were prepared for recombi-
neering essentially as described (28,39). Brieﬂy, cells were
diluted 1/50 from a fresh overnight culture in LB broth at
358C and grown to between 0.3 and 0.4 OD600. The pL
promoter was de-repressed by incubation at 428C for
15min with optimal induction of the lredgam genes
requiring longer incubation for some of the 23S rRNA
mutants (see Results section for further detail). Induced
cultures were chilled by constant swirling in an ice/water
bath for 5–10min and cells were pelleted by centrifuga-
tion. Cell pellets were washed in 2  their original volume
of ice-cold water, pelleted and washed again in 1/20
their original volume with ice-cold water. After a ﬁnal
centrifugation step in a 1.5ml microfuge tube, cells were
resuspended to 1/100 their original volume in ice-cold
water and used immediately for electroporation.
For linear DNA transformation, 50ml of cell suspension
was mixed with  100ng DNA, transferred to a pre-chilled
electroporation cuvette (1mm), and pulsed at 1.8kV in
a Biorad Gene Pulser Xcell (Hercules, CA). Cells were
transferred to a 15ml tube (Falcon 2059) containing 1ml
LB and placed at 358C with shaking for outgrowth.
Selection of tolC
+ recombinants was performed after a
2-h incubation followed by plating 0.1ml onto LB agar
containing 0.01% SDS. Most experiments yielded between
1.6 10
4 and 2.3 10
6 SDS-resistant transformants per
5 10
8 total cells. Selection of SDS
R transformants for
some of the 23S rRNA mutants required extended out-
growth times (see text).
To select for loss of the tolC marker, cells were
incubated after electroporation for 5h to allow for TolC
turnover. Typically, 10ml of cells was then transferred to
a fresh tube containing 65ml of LB and 200 units colicin
E1 and incubated for 60min at 358C with shaking.
Aliquots are plated on LB agar and grown overnight at
358C. Most experiments yielded colicin-resistant recombi-
nants at an  0.015 frequency. The colicin E1 tolerance
of the resulting recombinants can be conﬁrmed by a
modiﬁed plate receptor test where, for instance, a 15ml line
of colicin E1 (8 units/ml) is pipetted down the center of
an LB plate and each transformant is cross-streaked using
a ﬂat toothpick. Sensitivity was scored as a clear zone
over the colicin E1line.
Preliminary characterization ofengineered rRNA mutants
Southern blots were performed as described (41) using
standard procedures. Genomic DNA samples were
prepared using the DNeasy Blood and Tissue kit
(Qiagen Valencia, CA) and treated with restriction
endonucleases BamHI and PstI (42). The 23S rDNA
region from HpaI to SalI was PCR ampliﬁed from strain
RS205 with the following primers 50-ACGCTTCTCGCT
CTCAACC-30 (Rx-P200) and 50-GAATAGGGGAGCC
GAAGGG-30 (Rx-P201) then labeled with
32P-NTP for
use as probe.
Growth characteristics of the diﬀerent rRNA mutants
were determined by luminescence using BacTiter
Glo (Promega) from 50ml broth cultures in 250ml
Erlenmeyer ﬂasks at 378C using an orbital shaker set
at 180rpm. Doubling time was calculated according to
the following: tgen=1/k where the growth rate constant
k=logXt-logX0/0.301t with X equal to cell number
(lumens). Sensitivity to various antibiotics was assessed
in LB broth according to CLSI procedures with minor
modiﬁcations (43).
Figure 1. Deletion of tolC from the E. coli genome and cassette design.
Fragments of chromosomal DNA are depicted with bent lines. Target
genes (tolC and recA) are denoted by colored boxes; neighboring genes
that encode open reading frames are shown with shaded boxes. P2 and
P1 refer to the promoters of tolC;P nudF and PrecA drive expression of
the nudF and recA genes, respectively. (A) Strategy for deleting tolC
from the chromosome. Recombination using the single-stranded DNA
molecule tolC Oligo (Rx-P15) and l redgam is depicted. The Rx-P15
oligo contains 35 bases of DNA directly homologous to sequences
ﬂanking tolC on the chromosome (curvy lines). The dotted line in
Rx-P15 is merely a representation demonstrating that the two halves of
the 70-base oligo are contiguous. Large X’s denote l red-mediated
cross-over between regions of homologous DNA. Following recombi-
nation and selection for colicin E1 resistance, the deletion of tolC from
the genome was conﬁrmed by PCR with primers shown as brown
arrows (Rx-P19 and -P20). (B) Ampliﬁcation of the tolC cassette and
deletion of recA. Oligo 1 (RxP-43) and Oligo 2 (Rx-P44) PCR amplify
a double-stranded tolC expression cassette. ORF X-change oligo
(Rx-P45) is used with RX-P46 (data not shown) to amplify only the
tolC open reading frame without its promoter. Curvy lines represent
homologous DNA shared by the linear DNA substrate and the bacte-
rial chromosome while large X’s again denote l red-mediated cross-
over between regions of homologous DNA. In this example, the tolC
expression cassette replaces the entire recA transcription unit (red) or
only the recA ORF (purple) conferring SDS resistance. A similar
strategy was used to delete the ara regulon, dicB and ygeX (data not
shown). PCR primers internal to tolC and complementary to neigh-
boring genes were used to conﬁrm insertion of tolC and deletion of the
target gene (see Figure 2 for an example). Removing tolC from its new
location followed the methodology in (A) above. The sequence and
description of all primers and oligos can be found in Table S2.
Illustrations not drawn to scale.
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published procedures (44). Brieﬂy, cells were grown to
mid/late log (OD600 0.9) in LB medium at 378C, concen-
trated by centrifugation, and frozen in liquid N2.
One-gram cell pellets were resuspended in 10ml of ice
cold 1X TMK (10mM Tris–Cl pH 7.5, 16mM MgAc,
60mM KAc, 1mM DTT) and lysed at 20–25000psi using
an EmulsiFlex C5 high pressure homogenizer (Avestin
Inc. Ottawa, Canada). Cell lysate was cleared by centri-
fugation at 30000g for 30min at 48C. Supernatant was
mixed with sucrose to 220mM ﬁnal and centrifuged for
53min at 90000gave (48C) to remove additional debris.
Ribosomes were pelleted through a 20% v/v cushion of
1.1M sucrose by centrifugation at 150000gave for 18h
at 48C, washed and resuspended in 1X TMK. A total of
10–30% sucrose gradients were prepared in 1X TMK
using a Gradient Master (Biocomp Inc. Edenton, NJ) and
ribosomes (2 OD260nm units/0.1ml) were analyzed follow-
ing centrifugation in a SW60Ti rotor (Beckman Fullerton,
CA) at 237000g, 2h, 78C using a continuous ﬂow UV
monitor (Amersham Biosciences Piscataway, NJ).
RESULTS
Deletingthe tolCpromoter andcoding region
As a ﬁrst step in testing whether tolC could be used as both
a positive and negative selectable marker, a strain lacking
the tolC coding sequence was constructed. The strategy
for removing tolC from its normal location at 68.5min on
the E. coli chromosome is shown in Figure 1A. Lambda
recombineering was used to delete the gene, simultaneously
demonstrating proof of principle for the strategy out-
lined earlier. Single-stranded DNA oligonucleotides were
designed to have 35 bases of exact sequence homology to
regions up and downstream of the tolC coding sequence.
Recombination directed by this 70-base oligo (Rx-P15)
would remove the tolC coding sequence in addition to its
proximal promoter (P1), leaving the P2 promoter com-
pletely intact and slightly truncating the nudF promoter.
When transformed to redgam-induced RS205 and selected
for tolerance to colicin E1, Rx-P15 was able to remove the
tolC gene with 25% eﬃciency (Table 1). Deletion of tolC
was conﬁrmed by PCR using primers directed against
sequences within nudF andygiB (Figure 1A) andthe colicin
E1 tolerance of the transformants was conﬁrmed using the
modiﬁed plate receptor test (data not shown). Oligonu-
cleotide Rx-P17 (which leaves both P1tolC and PnudF
intact) was just as eﬃcient at removing tolC. When using
DNA oligonucleotides exactly complementary to Rx-P15
and Rx-P17 (i.e. homologous to the lead replicating gDNA
strand), tolC gene deletions were not detected under
the same experimental conditions (data not shown).
Thus, selection for tolC removal is possible through the
use of colicin E1 and the resulting strain, RS206, can be
used to test tolC’s eﬃciency as a positive selectable marker.
Design,constructionandtesting ofatolCexpression cassette
With the tolC coding sequence and promoter deleted from
the chromosome of RS206, a tolC expression cassette was
ampliﬁed by PCR from the gDNA of RS205 (tolC
+).
Oligonucleotides were designed to amplify the region
coding for the P1 tolC promoter and the entire tolC open
reading frame with 50-base tails homologous to regions
ﬂanking an appropriate target gene (Figure 1B). The
E. coli recA gene was selected as an appropriate candidate
for testing if a target gene could be deleted using l recom-
bineering and tolC as a selectable marker. Upon intro-
duction of the recA-tolC cassette into RS206 and selection
of SDS resistance, resultant colonies were screened by
PCR using primers located within the tolC cassette and
those from neighboring genes (oraA and ygaD). The use of
tolC as a selectable marker was highly eﬃcient, as 100% of
transformants tested (24 out of 24) demonstrated removal
of recA and insertion of the tolC cassette.
TolC’s facility as a selectable/counter selectable marker
prompted a more detailed investigation of the selection
parameters used during the proof of principle experi-
ments. SDS selection was optimized by testing LB
agar plates containing various concentrations of SDS or
through direct spreading of SDS onto pre-poured LB agar
plates (20ml) before addition of cells. Both methods were
successful as little to no background growth of SDS
sensitive colonies was detected at SDS concentrations as
low as 0.002%. Concentrations of SDS as high as 1%
(10mg/ml) were also tolerated (data not shown). Fixing
the SDS concentration at 0.01% was suﬃcient to select for
deletion of the entire arabinose operon from the E. coli
genome, as well as the dicB and ygeX genes (Table 1) and
for insertion of tolC into low- and medium-copy plasmids
(data not shown).
A slightly diﬀerent approach was used for colicin E1
counter-selection. As opposed to incorporating colicin E1
into agar (where background growth was problematic),
the peptide was added to transformed cells in small
Table 1. Recombineering with tolC
Target Insertion method Eﬃciency
of tolC
insertion
Deletion
method
Eﬃciency
of tolC
removal
tolC N/A N/A ss Oligo 25%
recA PtolC Cassette 100% ss Oligo 86%
recA PtolC Cassette 100% ds PCR
product
100%
araCBAD PtolC Cassette 100% ss Oligo 77%
dicB PtolC Cassette 100% ss Oligo 89%
ygeX PtolC Cassette 100% ss Oligo ND
rrIC PtolC Cassette 13% ss Oligo 100%
recA tolC ORF-Xchange 100% ND ND
dicB tolC ORF-Xchange 0% ND ND
ygeX tolC ORF-Xchange 0% ND ND
A list of target genes for testing the eﬃciency of the tolC selectable/
counter-selectable marker system is shown in column one. The table
lists the methods used to insert tolC (either through a promoter-
containing tolC cassette or through ORF-X change) and the methods
used to remove tolC (either by using a single-stranded oligo or a
double-stranded PCR product). Conﬁrmation of tolC insertion or
removal was performed by PCR (see Figure S2 for primers), phenotype
analysis, and DNA sequencing when appropriate. The eﬃciencies for
each method were calculated as follows: (number of recombinants
testing positive for the insertion or deletion event/total number of
resistant colonies tested) 100. Deletion of tolC following ORF-X
change was not performed. ND: not determined.
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Methods section. This simple method proved econom-
ical and successful as background growth was avoided.
A variety of colicin E1 concentrations were tested in this
fashion using the single-stranded DNA oligonucleotide
strategy (Figure 1A) to remove tolC from the recA, ara
and dicB loci (data not shown). A concentration of
2 units/ml (ﬁnal) yielded reproducible results and removal
of tolC by colicin E1 counter-selection was 86, 77 and 89%
eﬃcient, respectively (Table 1). Deletion of tolC from the
recA locus was also performed with a double-stranded
PCR product and 50bp homology arms. This long, linear
DNA (1197bp) was 100% eﬃcient at deleting tolC from
the recA locus (Table 1).
The tolC marker system was also used to create
in-frame fusions to speciﬁc genes in E. coli. A promoter-
less tolC cassette was designed to replace the open reading
frame of a speciﬁc target gene (coined ORF-Xchange
in this work) leaving the promoter and other regulatory
sequences of that gene intact (Figure1B). TolC ORF-
Xchange would provide a preliminary indication of essen-
tiality and expression level of that particular target gene.
Simultaneous testing of that same target gene for replace-
ment using the promoter-containing tolC cassette would
help conﬁrm or deny essentiality. Final demonstration
of essentiality would rest on successful and eﬃcient
ORF-Xchange only when a complementing copy of the
target gene was provided. To demonstrate that TolC
can function in this capacity, ORF-Xchange experiments
were performed on recA (a constitutively expressed,
non-essential gene), dicB (a tightly regulated gene whose
essentiality is controversial) and ygeX (a minimally
expressed, non-essential gene). The recA coding sequence
was replaced by tolC ORF-Xchange at 100% eﬃciency
(Table 1). ORF-Xchange was not successful for dicB
or ygeX (no SDS-resistant recombinants found compared
to recA), but subsequent deletion of both genes by the
promoter-containing tolC cassette was 100% eﬃcient
(Table 1). The essential genes metG and murA could not
be replaced by either tolC cassette unless a complementing
copy of those genes was provided on a plasmid [data not
shown; (39)].
Remodeling the rRNA operons ofEscherichia coli using tolC
As further proof of tolC’s utility as a selectable/counter-
selectable marker for l recombineering, the genes encoding
ribosomal RNAs were targeted for deletion. Escherichia
coli contains seven diﬀerent rRNA operons that map to
various locations on the genome (Figure S3) (45). Deleting
entire rRNA operons is not novel, as there is published
work that used classically elegant genetic techniques to
delete six and even all seven rRNA operons from the E. coli
genome (46,47). Due to technical limitations, however, the
strains containing a single rRNA operon require comple-
mentation by aplasmidthatprovides essential tRNA genes
removed from the genome during the original genetic
manipulations (46,47). So, a more precise manipulation of
the E. coli rRNA operons was performed using the tolC
marker system and lredgam with the intention of main-
taining the structural ﬁdelity of those complex operons and
eliminating the requirement for extra-chromosomal
elements.
To that end, the gene encoding 23S rRNA was targeted
exclusively for removal from all but one of the ribosomal
RNA operons. Given the extraordinarily high degree
of sequence homology among the seven rRNA operons,
a universal tolC cassette (with promoter) was designed
that would allow for deletion of any rrl gene regardless of
its location on the E. coli genome. DNA oligonucleotides
were synthesized for ampliﬁcation of a tolC cassette that
would contain 50-nucleotide tails homologous to regions
just upstream and downstream of the rrl genes (see the
rrlC example shown in Figure 2). The oligos were designed
speciﬁcally so that tolC insertion would occur just after the
last tRNA gene following 16S rDNA in all operons,
deleting both RNAse III half-sites and the 23S rRNA gene
itself. Following removal of the tolC cassette by a single-
stranded DNA oligonucleotide, the proper arrangement
of secondary RNase processing sites would be restored,
Figure 2. Strategy for remodeling the Escherichia coli rRNA operons.
A tolC cassette is shown ampliﬁed by rrlX oligos For and Rev (Rx-P50
and -P51, respectively) having universal homology arms that corre-
spond to sequences ﬂanking the 23S rRNA genes from all seven
operons (Figure S3). In this example, removal of rrlC occurs following
introduction of the tolC cassette and recombination. SDS-resistant
colonies are screened by PCR using tolC Chk primer1 (Rx-P71) paired
with an operon-speciﬁc primer (Px-P52 through P58). This screening
can be multiplexed as primers were designed to amplify fragments of
distinct sizes (Figure 3). Following conﬁrmation of tolC insertion, the
cassette is removed by introducing universal single-stranded oligos
(RX-P59 or P60, depending on the direction of replication). After
selecting for colicin E1 resistance, transformants are screened by plating
on SDS and by PCR using a 16S rDNA primer with the operon speciﬁc
primers mentioned before. Fragments of chromosomal DNA are
depicted with bent lines. P2 and P1 refer to the promoters that drive
expression of the rRNA operons and PtolC represents the P1 promoter
for that gene. Neighboring genes are shown with shaded boxes: gltU,
aspT and trpT encode tRNA; rrsC and rrfC encodes 16S and 5S rRNA,
respectively. Green diamonds represent RNase III processing sites. Blue
diamonds represent RNAse E processing sites for tRNA and 5S RNA.
Primers used for PCR screening are shown with brown arrows. Curvy
lines represent homologous DNA shared by the linear DNA substrate
and the bacterial chromosome while large X’s again denote l red-
mediated cross-over between regions of homologous DNA. Illustrations
not drawn to scale.
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rRNA (rrf) and tRNA genes (Figure 2). Insertion and
removal of the tolC cassette from speciﬁc rRNA operons
was conﬁrmed by PCR using a primer internal to tolC,
a universal 16S rDNA primer common to all operons, and
an operon-speciﬁc primer (Figure 2).
The rrlX-tolC cassette was electroporated to strain
RS526 (RS206 recA ara tolC) following induction of
lredgam at 428C. Replacement of 23S rRNA genes with
tolC in each operon was assessed by PCR using the tolC
check primer and the speciﬁc primer from each rRNA
operon. All SDS resistant recombinants showed deletion
of 23S rRNA genes with no overt position eﬀects as
judged by the fact that tolC inserted into each of the seven
operons with approximately equal frequency (data not
shown). When a tolC cassette was designed to insert and
establish transcription convergent to the strong tandem
rRNA promoters P1P2, no recombinants were detected
due presumably to antisense suppression of tolC (data not
shown). Colicin E1 counter-selection was performed in
the presence of the single stranded rrlX-tolC oligo to
remove the tolC cassette from rrnC (Figure 2). A 100% of
the colicin E1-resistant colonies (48 out of 48) were SDS
sensitive and had tolC removed as detected by PCR using
primers Rx-P54 and Rx-P61 (Tables 1 and S2). These
results demonstrate that the tolC marker system allows
for seamless modiﬁcation of the rRNA operons with no
polar eﬀects.
Starting with a tolC insert in rrlG, successive rounds of
deletion/insertion were performed until only one rRNA
operon contained the DNA encoding 23S rRNA (rrnC).
Deletion of tolC using the single-stranded oligo strategy
also demonstrated lagging strand bias speciﬁc to each
rRNA operon (data not shown). PCR screening data from
select strains is shown in Figure 3A. Using the 16S rDNA
universal primer and primers speciﬁc for each operon,
the wild-type strain gives large PCR products (4–5kb)
demonstrating the presence of the 23S rRNA gene in each
operon. The tolC
  strain deleted for rrlDGH (Figure 3A,
middle section) shows smaller PCR products indicating
the removal of the 23S RNA genes from those operons.
The strain deleted for all but one 23S rRNA gene shows
a WT PCR fragment only for rrlC. To conﬁrm deletion
of the appropriate 23S rRNA gene(s) from each strain,
a Southern blot was performed using a probe directed
against 23S rDNA (Figure 3B). The absence of the corre-
sponding band in each of the respective strains veriﬁes the
deletion of the 23S rRNA genes from the E. coli genome.
The restoration and proper alignment of RNase E proces-
sing sites was conﬁrmed by DNA sequencing (data not
shown).
Preliminary characterization ofthe new rrl mutantstrains
During construction of these new E. coli rrl mutants,
it became obvious that growth rate decreased in relation
to the copy number of 23S rRNA genes present on the
chromosome. Upon completion of the single-copy rrlC
mutant (RS676), growth analysis was performed on the
entire strain set according to the procedures outlined in
Materials and Methods. The doubling time of each strain
is reported in Table 2. RS526 (tolC recA ara) is the
isogenic parent of all the rrl mutants (designated as wild-
type-WT) and has a doubling time of 39min. Deletion of
rrlG and the double deletion rrlGH increase generation
time compared to WT by 21 and 47%, respectively. Inter-
estingly, mutants that contain ﬁve, four, three and two
functioning 23SrRNA gene copies all have doubling times
between 57 and 60min. Strain RS676 (single copy of a 23S
rRNA structural gene in rrnC) has the longest generation
time, 87min.
Given that RS676 has only one copy of the gene
encoding 23S rRNA and seven intact copies of the 16S
rRNA gene, it was tempting to reason that such a mutant
would be unable to maintain the proper ratio of 30S/50S
ribosomal subunits. In order to address this point, ribo-
somes were puriﬁed from RS526 (WT), RS547 (rrlDGH)
and RS676 (single-copy rrlC). Figure 4 shows the sedi-
mentation proﬁles of ribosomes from these strains after
analysis by sucrose density gradient centrifugation. The
ribosome proﬁle diﬀers among the three strains, with the
Figure 3. Conﬁrmation of 23S rRNA deletions. (A) Agarose gel
showing PCR products generated from gDNA of select E. coli strains.
Strain RS526 (WT rrl) has all rRNA operons intact and yields large
( 4–5kb) PCR products when the 16S and operon-speciﬁc primers are
used (Figure 2). The rrlDGH strain (RS547) shows smaller PCR
fragments demonstrating the deletion of 23S rRNA genes from the
respective operons. Lastly, strain RS676 (rrlABDEGH) has only one
copy of the gene for 23S rRNA located in the rrnC operon. Lanes 1
and 23: Marker DNA (1kb ladder and 0.1kb ladder, respectively).
(B) Southern blot demonstrating the step-wise removal of 23S rRNA
genes from six of the seven operons. The sizes of the DNA bands and
corresponding operons follow: rrnC—16.9kb; rrnG—15.5kb; rrnE—
11.2kb; rrnH—9.6kb; rrnD—8.1kb; rrnB—7.2kb and rrnA—6.6kb.
Strain designations: WT- RS526, 1- RS537, 2- RS544, 3- RS547,
4- RS550, 5- RS554 and 6-RS676.
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of 23S rRNA genes drop. The 6 strain (containing only
rrlC) has the least amount of free 50S ribosomal subunits
and an excess of free 30S subunits compared to both WT
and the 3 mutant.
To determine whether the diﬀerences in ribosome
proﬁles might confer upon the rrl mutant strains an easily
testable phenotype, their sensitivity to a number of well-
characterized antibiotics was measured (Table 2). The
minimum inhibitory concentration (MIC) of the cell wall-
targeting antibiotic ampicillin did not change for any of
the mutants tested. Similarly, there is no diﬀerence in the
MIC values for rifampin (targets RNA polymerase and
transcription) and novobiocin (targets DNA gyrase and
replication). These results suggest there is little, if any,
detectable eﬀect of the rrl mutants on essential cellular
processes not relating to protein synthesis. The rrl mutants
were also tested with drugs and antibiotics that block
protein synthesis through binding to either the 30S or 50S
subunits oftheribosome. Table2showsthatall rrl mutants
are comparable to WT in their sensitivity to ribosome
targeting compounds under the conditions tested.
DISCUSSION
Genome engineering has undergone remarkable
advances due to the development of eﬃcient systems for
recombination in model organisms like E. coli
(25,27,28,48,49). It is now routine to create deletions and
point mutations in target genes (on the chromosome or
on plasmids) using DNA oligonucleotides and PCR
(26,32,50,51). This study describes the development of
novel methodology that uses the gene coding for a single
open reading frame, tolC, as both a selectable and
counter-selectable marker for genome engineering studies.
TolC selection obviates the need for minimal media,
specialized wash protocols, extended incubation times and
the traditional antibiotic selections required by other
techniques.
Historically, selectable markers used in recombinant
DNA work have been small genetic elements that express
cytoplasmic enzymes or proteins conferring resistance to
antibiotics (52). Use of tolC as a genetic marker is some-
what unorthodox in that the gene encodes an outer
membrane protein that forms a transperiplasmic channel
through which various eﬄux pumps extrude toxic
molecules from the bacterial cell (10). TolC’s properties,
however, meet perfectly the requirements for use as a tool
in genome engineering especially when coupled with
the highly eﬃcient lredgam recombination system. In an
E. coli cell deleted for tolC, SDS and other small toxic
molecules are unable to be pumped eﬃciently from the
cell. Introduction of the tolC ORF confers relative
resistance to these compounds but for some molecules
(e.g. novobiocin) spontaneous resistance mutants may
also arise (53). Consequently, SDS was used in this work
as the reagent to select for tolC insertions as it causes cell
lysis and the frequency of spontaneous SDS-resistant
mutants is extremely low (<5 10
 10)i natolC null
background [data not shown, (54)]. Indeed, the data in
Table 1 show that SDS selection results in 100% recom-
bination eﬃciency at any unique targeted site and gives
no background at SDS concentrations as low as 0.002%
(data not shown). The eﬃciencies reported in Table 1 only
reﬂect proper placement of the tolC cassette at the
targeted site. The high frequency of recombination seen
with tolC is governed by the lredgam recombination
system itself (28,32,55) and is not inﬂuenced by SDS
selection. SDS selection is, however, economical and
allows for facile incorporation into molten agar without
Table 2. Preliminary characterization of rrl mutants
MIC (ng/ml)
Strain rrl Genotype tgen (min) Amp Nov Rif Cam Ery Kan Tet
RS526 WT 39 2 0.5 4 1 2 4 0.5
RS537 1-rrIG 48 2 0.5 4 1 2 4 0.5
RS544 2-rrlGH 58 2 0.5 4 1 2 8 0.5
RS547 3-rrlDGH 59 2 0.5 4 1 2 8 1
RS550 4-MDEGH 57 2 0.5 4 1 4 4 1
RS554 5-MBDEGH 60 1 0.5 4 1 4 4 1
RS676 6-rrlABEDGH 87 1 0.5 4 0.5 4 4 0.5
Bacterial strain numbers are listed in column one and their genotypes with respect to 23S rRNA genes are shown in column two (please refer to
Table S1 for complete genotype). Column three shows doubling time in LB media at 378C( tgen in minutes). Minimum inhibitory concentration
(mg/ml) of known antibacterial agents are shown for each strain tested in microtiter plates in LB broth at 358C. Amp: ampicillin; Nov: novobiocin;
Rif: rifampicin; Cam: chloramphenicol; Ery: erythromycin; Kan: kanamycin; Tet: tetracycline. Other agents tested but not shown: Linezolid,
Puromycin, Azithromycin, Kasugamycin, Spectinomycin, Fusidic Acid, and Kirromycin.
Figure 4. Ribosome sedimentation proﬁles from rrl mutants. Ribo-
somes were puriﬁed and analyzed by sucrose density gradient sedimen-
tation according to Materials and Methods. The positions and size
(S=Svedberg units) are shown: 70S=mature ribosomes, 50S=large
ribosomal subunits, 30S=small ribosomal subunits. WT- strain RS526
(rrl
+), rrlDGH- strain RS547 and rrlABDEGH- strain RS676.
PAGE 7 OF 12 Nucleic Acids Research, 2008, Vol. 36,No. 1 e4the need for cooling to intermediate temperatures as is
necessary with heat labile antibiotics. Furthermore, posi-
tive selection for tolC using SDS is performed on rich
media (LB) commonly used in many laboratories. There-
fore, recombinants often arise after only 16h (overnight)
incubation at 358C. This incubation period is similar to
other gene cassettes that select for chloramphenicol resis-
tance or gentamycin resistance (30,36) but those markers
are incapable of providing counter-selection. Finally,
when creating mutants to study gene regulation or other
aspects of E. coli physiology, the tolC strategy does not
require antibiotics or specialized media that might inter-
fere with facile experimental design or data interpretation
(see subsequently).
The key feature of TolC as a tool for genetic engineering
in E. coli is the ability to select for its absence from the
cell. A number of counter-selectable markers have been
developed to perform genetic manipulation with varying
degrees of success (31,32,34,35,52,56,57). Unlike tolC,
these counter-selectable markers must be used in tandem
with a gene that allows for positive selection. Though
widely applied, the sacB-neo fusion cassette involves anti-
biotic selection and sucrose toxicity (24) which can result
in high background after negative selection. Alternatively,
the rpsL gene has been coupled with neo to provide
concerted antibiotic selection (32). In a bacterial strain
containing a mutant rpsL gene on the chromosome, loss of
a second copy of wild-type rpsL converts the cell from
streptomycin-sensitive to streptomycin-resistant (57). Two
recent eﬀorts coupled the lredgam recombineering system
with either galK or thyA selection in E. coli (37,38). These
and other auxotrophic markers can be used quite readily
in a positive selection mode, allowing recombinants
having these markers integrated into the chromosome to
grow on minimal media. Clever counter-selection methods
were utilized to permit eﬃcient removal of galK and thyA
by incorporating 2-deoxygalactose and trimethoprim/
thymine, respectively, into agar plates. Such methods,
however, require extensive washing of cells to reduce
background during positive selection (since minimal
media is required) and recombinants appear only after
3-days growth (35,37,38).
Like the galK and thyA techniques, the tolC system
also provides for eﬃcient counter-selection. Through its
surfaced exposed residues, the TolC protein allows import
of colicin E1, a bactericidal protein that normally func-
tions as part of an antimicrobial defense system (14).
Therefore, cells containing tolC are lysed when exposed to
colicin E1. This feature of the tolC counter-selection
strategy helps to reduce background without the need
for specialized wash protocols (35,37,38). Furthermore,
the procedure can be performed in rich media, allowing
recombinants to grow after only 16h incubation. The
short incubation time is advantageous as it permits PCR
screening of colonies and phenotypic testing for both SDS
sensitivity and colicin E1 resistance/tolerance all within
one workday following electroporation.
The eﬃciency of colicin E1 counter-selection against
the tolC cassette using single-stranded oligonucleotides
is quite high, generally 80–100% for targets that map
to various locations on the genome (Table 1 and data
not shown). Removal of tolC from its normal location
(using ss DNA) on the E. coli chromosome was, however,
less eﬃcient with only 25% of the E1-resistant recombi-
nants demonstrating tolC deletion. The lower eﬃciency in
this case could be due simply to sub-optimal recombineer-
ing conditions. Alternatively, genome position eﬀects or
the minimal length of the single stranded oligonucleotides
used as a recombination substrate may have also contri-
buted to the reduced eﬃciency. Increasing the eﬃciency of
tolC deletion at this locus might be achieved by length-
ening the ss-oligo to provide more than 35 bases of
homologous sequence ﬂanking the tolC target or by using
double stranded DNA to increase homology further.
Ellis et al. (55) showed that when using linear DNA in this
way, recombination eﬃciency can improve with increased
length, a fact conﬁrmed by the removal of tolC from the
recA locus at 100% eﬃciency using a double-stranded
PCR product (Table 1). Such experiments were not
performed on the tolC locus as additional manipulation
was not required to demonstrate proof of principle.
An alternative to colicin E1 for counter-selection of tolC
was tried but did not yield favorable results. TLS phage
uses TolC as a receptor for attachment to E. coli and
following infection and replication inside tolC
+ strains,
TLS kills the cell (17). Removal of tolC from the ara locus
was attempted using TLS phage counter-selection on
agar plates and in broth. Individual recombinants often
demonstrated weak phage resistance (upon puriﬁcation
and phage cross-streak) as well as the ability to retain
resistance to SDS (data not shown). As the colicin E1
counter-selection provided favorable results and is not
aﬀected by unforeseen changes in surface lipopolysacchar-
ides, further optimization of TLS phage for selection was
not pursued.
Colicin E1 selection is not without drawbacks as
E1-resistant (or tolerant) mutants can arise through
spontaneous mutation of btuB or tolC. The involvement
of btuB mutants can be identiﬁed easily by screening
colonies in the plate receptor test (23) and patching on
SDS-containing media. Mutations in btuB would appear
colicin-resistant, but SDS-resistant as well. In addition,
point mutations in tolC that interfere directly with colicin
E1 binding and/or translocation but remain eﬄux
competent (15) would also be identiﬁed through this
counter-screen. In fact, most of the infrequent E1-resistant
recombinants shown not to have tolC deletions by PCR
fell into this category (data not shown). Particular muta-
tions in tolC (L3S, L3, L412P, and C-terminal deletions)
confer both novobiocin sensitivity and colicin E1 resis-
tance (58–60), but none have been speciﬁcally reported for
SDS and colicin E1. Nevertheless, such spontaneous
mutations could interfere with eﬃcient counter-selection
using the method described in this work. Mutations at
multiple loci (e.g. mutations in both tolC and an eﬄux
pump) could also confound selection as such cells might
be both colicin E1-resistant and SDS-sensitive. Given the
extremely high recombination rates catalyzed by l redgam
(28), these potential false positives were not problematic
and eﬃcient selection against tolC was possible (Table 1).
Along the same lines, removal of the tolC cassette
may occur through recombination at repetitive sequences
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occur irrespective of the counter-selectable marker used
and the tolC strategy cannot overcome this inherent
drawback of the system. Recombinants that have lost
tolC expression through recombination at ﬂanking repeats
would also be colicin E1-resistant and would appear as
false positives during selection. PCR testing with primers
that bracket the proper deletion junction (as shown in
Figure 2) would exclude these false positives. Thus,
Table 1 reports eﬃciencies that reﬂect only proper
removal of tolC from the targeted site. Interestingly, the
highly homologous ribosomal operons of E. coli represent
a situation where deletion through ﬂanking repeats may
occur (see subsequently).
As mentioned previously, the tolC marker system does
not require specialized media or small molecule antibiotics
and can be used economically in laboratories familiar
with the growth and manipulation of E. coli strains in the
course of normal molecular biology protocols. A potential
confounding factor of the technique is that antibiotic
resistant markers are not needed. While this can be advan-
tageous when studying physiological processes that may
be altered by the presence of antibiotics, lack of antibiotics
does permit the growth of contaminants in the absence of
proper sterile technique. Should contamination be proble-
matic, a straightforward conversion of the tolC parent
strain to streptomycin resistance by creating a point
mutation in rpsL using l redgam may oﬀer a solution.
The strategy of colicin selection may have broader
application to other model organisms where a dearth of
genetic tools has hampered progress toward understand-
ing molecular processes. For instance, some archae-
bacteria synthesize and respond to peptide toxins called
halocins (19). The receptors and molecular targets of these
toxins have not been fully characterized, but they may
provide a similar set of tools for genome engineering in the
archaea. In fact, an outer membrane protein with weak
sequence homology but functional similarity to E. coli
tolC has been identiﬁed in Chromohalobacter marismortui
(61) Given that archaea are known to take up and
recombine linear DNA (62,63), a gene disruption strategy
similar to that described in this work may have potential.
As shown in the Results section, the tolC marker system
can also be used to assess the essentiality and expression
levels of various target genes through ORF-Xchange.
A similar strategy was recently described in detail using
antibiotic resistant markers (64). For a constitutively
expressed, non-essential gene like recA, ORF-Xchange
with tolC occurred at high frequency and was 100%
eﬃcient (Table 1). The product of the dicB gene stimulates
MinC function and interferes with normal cell division
(65,66). DicB synthesis is tightly regulated (67), and
is one of the least abundant mRNAs/proteins found
in the E. coli cell (  60-fold less than recA) (68). Its essen-
tiality has been questioned, however, as some groups have
reported conﬂicting results using various experimental
techniques (69,70). Table 1 shows that the promoter-
containing tolC cassette is able to delete the dicB gene
with 100% eﬃciency, conﬁrming its non-essentiality.
In addition, dicB’s low expression level was conﬁrmed by
unsuccessful ORF-Xchange under standard SDS selection.
Similar results were obtained for ygeX, a gene of unknown
function whose expression levels are just slightly below
that of dicB (68). In agreement with previous results (39),
deletion of the known essential genes murA and metG
could not be achieved with high frequency by either tolC
cassette unless a complementing copy of either gene was
provided. These data demonstrate that the tolC marker
system can be used successfully to screen for gene essen-
tiality and expression in the same manner as described by
Bubunenko et al. (64).
Perhaps the best demonstration of the utility and
reproducibility of tolC selection/counter-selection is the
seamless modiﬁcations made in six of the seven 23S rRNA
genes on the E. coli chromosome (Figure 3). These genes
occupy various positions on the genomic map and reside
in complex operons interspersed between other essential
structural rRNA and tRNA genes (Figure S3) (1,71).
The intergenic sequences of the rRNA operons contain
RNAse cleavage sites necessary for the correct processing
and maturation of the individual cistrons (Figures 2
and S3) (72). In addition, there is a high degree of
sequence homology among the RNA coding sequences
and among the intergenic regions (73). Such features make
directed genetic modiﬁcation of the individual rRNA
genes on the chromosome a challenging task. Previously
published work was relegated to creating large deletions in
the rRNA operons (46,74).
As this work describes, the tolC marker system provides
the tools necessary to precisely remodel the rRNA
operons in E. coli. The keys to this advancement are the
use of bacteriophage l’s redgam recombination system
combined with tolC’s selection properties: namely the
ability to use rich media without traditional antibiotic
markers. Successful deletion of the rrlC gene alone
(Figure 2, Table 1) demonstrates that tolC modiﬁcation
of the ribosomal operons can be achieved without confer-
ring polar eﬀects. RS1443 (rrlC strain) has a growth
phenotype indistinguishable from RS537 (rrnG), with
no observable defect in protein synthesis, as maximal l
redgam induction occurs within 15min as seen with the
parent strain (data not shown). Since the viability of
RS1443 depends upon proper expression and processing
of the essential tryptophan tRNA (trpT) gene located
downstream, these results establish that trpT expression is
not disturbed by the genetic manipulations performed and
that the experimental design shown in Figure 2 is sound.
Using this strategy, deletion of six 23S rRNA genes
was straightforward (Figure 3). Mutations in any rRNA
operon were maintained by preventing homogenotization
through the use of the recA deleted, RS526 strain back-
ground. The decision to leave rrnC as the only intact
operon was based on its proximity to the origin of DNA
replication, with the intention that gene dosage eﬀects
might provide a more favorable growth rate to a single-
copy mutant (74,75). In fact, the ability to perform these
genetic manipulations in rich media was crucial as the
growth rate of cells with decreased 23S rRNA gene copies
was signiﬁcantly reduced (Table 2). Interestingly, mutants
with two to ﬁve copies of 23S rRNA genes had very
similar growth rates (2.2% SD between strains) but were
collectively  34% slower than their isogenic parent.
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genes from the chromosome of E. coli has a pronounced
eﬀect on protein synthesis. This was observed indirectly
through assessment of the time required for suﬃcient
lredgam induction to yield recombinants at non-essential
loci. For example, where a 15min induction at 428C
yielded thousands of recombinants in the WT strain,
a minimum of 60min was required for strains having only
one or two copies of the 23S rRNA gene (data not shown).
The 5 strain (RS554) required 2.5  more time for
induction than the 3 strain (RS547) while the single-copy
strain (RS676), despite its even slower growth rate, was
comparable to RS554 for redgam induction (data not
shown). Given the unique construction of these mutants,
decreases in 23S rRNA gene copy number may not yield
predictable changes in growth rate and ribosome eﬃ-
ciency. Although the increase in doubling time is similar
to that seen with other rRNA deletion strains reported in
the literature (46,75), a direct comparison is diﬃcult as
the strains constructed here are not deleted for entire
rRNA operons nor are plasmids used to provide essential
functions to the cell. Therefore, a more thorough investi-
gation of the physiological properties of these new
mutants is required.
As a ﬁrst step towards understanding the molecular
basis of the mutant phenotypes, the ribosome proﬁles
from select mutant strains were determined (Figure 4).
Reducing the number of 23S rRNA genes aﬀected the
ribosome proﬁles of the mutants constructed in this work.
The 3 mutant (having four copies of 23S rRNA genes),
shows an increase in free 30S and 50S ribosomal subunits
compared to WT but a reduced amount of 70S ribosomes.
The eﬀect is more pronounced in the single-copy rrlC
strain RS676 where 70S ribosomes and free 50S subunits
levels are further reduced compared to WT, but an excess
of 30S subunits is present. This imbalance in ribosome
content could account for the observations concerning
growth rate and protein synthesis discussed in the previous
paragraph. A similar imbalance has been detected in ribo-
somes from normal cells grown at 168C (76), from cells
over-expressing incomplete rRNA genes from plasmids
(77), and from cdsA mutants when grown at low tempera-
tures (78). The cdsA mutants, however, lead to accumula-
tion of a 40S particle not yet seen with the mutants
described in this work. In the studies where a 30 segment of
23S rRNA was expressed from a plasmid, it was deter-
mined that the material sedimenting at 30S was misfolded
23S rRNA bound to an incomplete complement of ribo-
somal proteins (78).
The unbalanced ribosome proﬁle of RS676 prompted a
test of whether this strain (or any of the other mutants)
showed altered sensitivity towards antibiotics that bind to
the E. coli ribosome given the potential for excess free 30S
ribosomal subunits to act as a sink for inhibitor binding.
Coupled with reduced 50S and 70S ribosomes levels,
this could make RS676 relatively resistant to antibiotics
that target the 30S ribosomal subunit. Upon testing all
mutant strains against a number of diﬀerent drugs and
antibiotics (Table 2), no clear diﬀerence was detected
under the conditions used. Interestingly, antibiotics that
target normal cellular processes not related to protein
synthesis (e.g. DNA replication, transcription, cell wall
biosynthesis) also showed no change in potency compared
to wild-type. These data suggest that the rRNA mutants
constructed do not suﬀer gross abnormalities in essential
cellular pathways.
The control of ribosome synthesis occurs at many levels
and it has been the focus of many comprehensive studies
[reviewed in (79,80)]. Ribosomal RNA synthesis is
regulated at both the initiation and termination steps of
transcription. The P1P2 promoters (shared by all rRNA
operons) are subject to the action of a transcriptional
activator (Fis), the alarmone ppGpp and the concentra-
tion of initiating nucleotide triphosphates (81). To prevent
premature termination of the untranslated rRNA tran-
scripts, antitermination mechanisms (similar to those used
by phage l), are also important (82). These and other
potential control mechanisms work together to ensure
that rRNA synthesis is proportional to the steady-state
growth rate of the E. coli cell (growth-rate-dependent
control) (83).
The synthesis of ribosomal proteins is regulated by
negative feedback inhibition of translation by free,
unassembled r-proteins (84). Ribosomal protein operons
are multi-cistronic and contain the genes encoding both
small and large r-proteins. In most cases, one r-protein
within an operon functions as an autogenous translational
repressor, binding to a site on the message and blocking
synthesis of all proteins in the operon (84). Coupled with
the growth-rate-dependent control of rRNA production,
these mechanisms help balance the synthesis of r-proteins
with rRNA and ensure the cooperative assembly of ribo-
somes in E. coli. Given the imbalance of ribosomal sub-
units noted for the single copy 23S rRNA mutant RS676
(Figure 4), it is tempting to speculate that remodeling
of the rRNA operons in the manner described here has
lead to a short-circuiting of the regulatory pathways that
control ribosome synthesis. Further investigation of this
and other rRNA mutants constructed with the tolC
marker system will guide additional studies on the regula-
tion of ribosome synthesis in E. coli.
Finally, the TolC selection method reported in this
work can be broadly applied to genetic manipulation
of any DNA substrate capable of ampliﬁcation within
E. coli. The construction of new plasmid vectors, point
mutations, deletions and insertions is possible using the
tolC marker system and lredgam. The type and speciﬁc
nature of the modiﬁcations are not limited by TolC selec-
tion. The method is highly reproducible and may serve as
suﬃcient replacement for other current selection systems.
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